美国开放性手术海绵市场：市场规模、份额、趋势分析（按产品和最终用途）、细分市场预测（2025-2033）

美国开放性手术海绵市场趋势：

2024 年美国开放性手术海绵市场价值为 4.227 亿美元，预计到 2033 年将达到 7.069 亿美元，2025 年至 2033 年的复合年增长率为 5.9%。

推动成长的关键因素包括癌症、疝气等疾病导致的腹部手术增多，以及剖腹产手术的增加。此外，对残留手术器械的担忧促使人们采用渗透性和支援RFID技术的海绵，进一步推动了需求成长。此外，人口老化、门诊病人手术数量的增加以及海绵设计和材料的进步也推动了成长，而强调手术安全和感染控制的法规也为这些因素提供了支持。

此外，手术安全，尤其是预防手术器械滞留（RSI），在美国日益受到关注。 RSI，尤其是海绵，是最常见且最危险的手术失误之一，会导致严重的併发症、再次手术、感染疾病，甚至死亡。例如，根据美国国家品质论坛（NQF）的数据，美国每年报告的手术器械滞留（RSI）案例有2000至4000例，其中最常见的是海绵。

开放性手术海绵用于无菌、高风险手术，包括切除手术。根据美国癌症协会统计，美国将新增约106,180例结直肠切除术，其中许多手术需要进行开腹手术（开放性手术），而海绵对于液体管理和组织牵拉至关重要。

永续性、人体工学设计和客製化定制正在成为美国市场开放性手术海绵发展的关键因素。随着医院越来越重视环保采购，製造商也纷纷采用环保材料、减少包装废弃物并采用可生物降解的组件来开发开放性手术海绵。这些创新与医院减少医疗废弃物和打造更环保手术室的更广泛目标相契合。在一个传统上註重功能性和成本的市场中，永续性正成为一种竞争优势，尤其是在那些致力于实现ESG（环境、社会和管治）目标的大型医院系统中。

同时，人体工学设计和针对特定手术的客製化设计正在提升手术效率和安全性。现代开放性手术海绵正在不断研发，其特点包括：边缘加固，更易于取出；质地改良，更易于液体吸收；以及颜色编码，方便术中追踪。此外，还提供针对外科专科（例如妇科肿瘤科和创伤护理）的客製化产品，确保其尺寸、形状和吸收性符合每种预期用途。

目录

第一章 分析方法与范围

第二章执行摘要

第三章美国开放性手术海绵市场：因素、趋势与范围

• 市场联动展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制分析
• 开放性手术海绵市场：分析工具
  • 产业分析：波特五力分析
  • PESTEL分析

第四章：美国开放性手术海绵市场：按产品分類的预测与趋势分析

• 细分仪表板
• 开放性手术海绵市场：产品差异分析
• 开放性手术海绵市场：产品展望
• 市场规模预测及产品趋势分析（2021-2033）
• 渗透性的开放性手术海绵
• 常规开放性手术海绵
• 带有RFID的开放性手术海绵

第五章美国开放性手术海绵市场：按最终用途的估计和趋势分析

• 细分仪表板
• 开放性手术海绵市场：以最终用途进行的变化分析
• 开放性手术海绵市场：依最终用途分類的前景
• 按最终用途分類的市场规模预测和趋势分析（2021-2033 年）
• 医院和诊所
• 其他的

第六章 竞争态势

• 市场参与企业分类
• 主要企业简介
  • Integra LifeSciences
  • Medical Action Industries Inc.
  • SDP Inc.
  • Dukal, LLC
  • Stryker
  • Cardinal Health
  • AllCare
  • DeRoyal Industries Inc.
  • Allmed Medical Products Co.,Ltd.
  • Premier Enterprises

U.S. Laparotomy Sponge Market Trends:

The U.S. laparotomy sponge market size was valued at USD 422.7 million in 2024 and is projected to reach USD 706.9 million by 2033, growing at a CAGR of 5.9% from 2025 to 2033. Key factors driving growth include a rise in abdominal surgeries due to conditions such as cancer and hernias, as well as an increase in C-sections. Demand is further enhanced by concerns regarding retained surgical items, which have led to the adoption of radiopaque and RFID-enabled sponges. Additionally, the growth is fueled by the aging population, increased surgical volumes in outpatient settings, and advancements in sponge design and materials, all supported by regulatory emphasis on surgical safety and infection control.

Additionally, the U.S. is witnessing heightened focus on surgical safety, particularly in preventing retained surgical items (RSIs). RSIs, especially sponges, are among the most common and dangerous surgical errors, leading to severe complications, repeat surgeries, infections, and even fatalities. For instance, according to the National Quality Forum (NQF), 2,000-4,000 cases of retained surgical items (RSIs) are reported yearly in the U.S., where sponges are the most frequently retained objects.

Laparotomy sponges are used in sterile, high-bleeding-risk operations, including resections. According to the American Cancer Society, approximately 106,180 new colorectal cases were recorded in the U.S., many of which require open (laparotomy) procedures, where sponges are essential for fluid management and tissue retraction.

Sustainability, ergonomic design, and targeted customization are emerging as influential factors in the evolution of laparotomy sponges in the U.S. healthcare market. As hospitals increasingly prioritize environmentally responsible procurement, manufacturers are responding by developing laparotomy sponges made with eco-friendly materials, reduced packaging waste, and biodegradable components. These innovations align with broader institutional goals of lowering medical waste and achieving greener operating room practices. In a market that has historically focused on functionality and cost, sustainability is now becoming a competitive differentiator, especially among large hospital systems aiming to meet ESG (Environmental, Social, and Governance) targets.

In parallel, ergonomic design and procedure-specific customization are enhancing surgical efficiency and safety. Modern laparotomy sponges are being developed with features such as reinforced edges for easier retrieval, improved texture for better fluid absorption, and color-coded systems to assist in intraoperative tracking. Some products are even customized based on surgical specialty-such as gynecologic oncology or trauma care, ensuring optimal size, shape, and absorbency for the intended use.

U.S. Laparotomy Sponge Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. laparotomy sponge market report based on product and end-use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Radiopaque Laparotomy Sponge
• Traditional Laparotomy Sponge
• Radio-frequency Identification (RFID) Laparotomy Sponge
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End-use
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End-use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. U.S. Laparotomy Sponge Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising number of laparotomy surgeries
    • 3.2.1.2. Growing prevalence of abdominal disorders
    • 3.2.1.3. Growing geriatric population
    • 3.2.1.4. Advancements in surgical safety regulations
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of laparotomy sponges
• 3.3. Laparotomy Sponge Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. U.S. Laparotomy Sponge Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Laparotomy Sponge Market: Product Movement Analysis
• 4.3. Laparotomy Sponge Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Radiopaque Laparotomy Sponge
  • 4.5.1. Radiopaque Laparotomy Sponge Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Traditional Laparotomy Sponge
  • 4.6.1. Traditional Laparotomy Sponge Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Radio-frequency Identification (RFID) Laparotomy Sponge
  • 4.7.1. Radio-frequency Identification (RFID) Laparotomy Sponge Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Laparotomy Sponge Market: End-use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Laparotomy Sponge Market: End-use Movement Analysis
• 5.3. Laparotomy Sponge Market by End-use Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Hospitals & Clinics
  • 5.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Market Participant Categorization
• 6.2. Key Company Profiles
  • 6.2.1. Integra LifeSciences
    • 6.2.1.1. Company overview
    • 6.2.1.2. Financial performance
    • 6.2.1.3. Product benchmarking
    • 6.2.1.4. Strategic initiatives
  • 6.2.2. Medical Action Industries Inc.
    • 6.2.2.1. Company overview
    • 6.2.2.2. Financial performance
    • 6.2.2.3. Product benchmarking
    • 6.2.2.4. Strategic initiatives
  • 6.2.3. SDP Inc.
    • 6.2.3.1. Company overview
    • 6.2.3.2. Financial performance
    • 6.2.3.3. Product benchmarking
    • 6.2.3.4. Strategic initiatives
  • 6.2.4. Dukal, LLC
    • 6.2.4.1. Company overview
    • 6.2.4.2. Financial performance
    • 6.2.4.3. Product benchmarking
    • 6.2.4.4. Strategic initiatives
  • 6.2.5. Stryker
    • 6.2.5.1. Company overview
    • 6.2.5.2. Financial performance
    • 6.2.5.3. Product benchmarking
    • 6.2.5.4. Strategic initiatives
  • 6.2.6. Cardinal Health
    • 6.2.6.1. Company overview
    • 6.2.6.2. Financial performance
    • 6.2.6.3. Product benchmarking
    • 6.2.6.4. Strategic initiatives
  • 6.2.7. AllCare
    • 6.2.7.1. Company overview
    • 6.2.7.2. Financial performance
    • 6.2.7.3. Product benchmarking
    • 6.2.7.4. Strategic initiatives
  • 6.2.8. DeRoyal Industries Inc.
    • 6.2.8.1. Company overview
    • 6.2.8.2. Financial performance
    • 6.2.8.3. Product benchmarking
    • 6.2.8.4. Strategic initiatives
  • 6.2.9. Allmed Medical Products Co.,Ltd.
    • 6.2.9.1. Company overview
    • 6.2.9.2. Financial performance
    • 6.2.9.3. Product benchmarking
    • 6.2.9.4. Strategic initiatives
  • 6.2.10. Premier Enterprises
    • 6.2.10.1. Company overview
    • 6.2.10.2. Financial performance
    • 6.2.10.3. Product benchmarking
    • 6.2.10.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. laparotomy sponge market, by product, 2021 - 2033 (USD Million)
• Table 4 U.S. laparotomy sponge market, by end-use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. laparotomy sponge: market outlook
• Fig. 9 U.S. laparotomy sponge market competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 U.S. laparotomy sponge market driver impact
• Fig. 15 U.S. laparotomy sponge market restraint impact
• Fig. 16 U.S. laparotomy sponge market strategic initiatives analysis
• Fig. 17 U.S. laparotomy sponge market: product movement analysis
• Fig. 18 U.S. laparotomy sponge market: product outlook and key takeaways
• Fig. 19 Radiopaque laparotomy sponge market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 20 Traditional laparotomy sponge market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 21 Radio-frequency Identification (RFID) laparotomy sponge market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Laparotomy sponge market, end use outlook key takeaways (USD Million)
• Fig. 23 Laparotomy sponge market end use movement analysis 2024 & 2033 (USD Million)
• Fig. 24 Hospitals & clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 26 Participant categorization- U.S. laparotomy sponge market
• Fig. 27 Market share of key market players- U.S. laparotomy sponge market